Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
108 studies found for:    Open Studies | "Amyloidosis"
Show Display Options
Rank Status Study
21 Recruiting The VITAL Amyloidosis Study, a Global Phase 3, Efficacy and Safety Study of NEOD001 in Patients With AL Amyloidosis
Condition: Primary Systemic (AL) Amyloidosis
Interventions: Drug: NEOD001;   Other: Placebo
22 Recruiting Study of Bortezomib +HSCT in Primary Systemic Amyloidosis (AL)
Condition: Amyloidosis
Intervention: Drug: Bortezomib
23 Recruiting Carpal Tunnel/Amyloidosis Blood Sample Study
Conditions: Carpal Tunnel Syndrome;   Amyloidosis
Intervention: Procedure: Blood Draw
24 Not yet recruiting Prevalence of Amyloidosis and Carpal Tunnel
Condition: Amyloid Neuropathy, Carpal Tunnel
Intervention:
25 Recruiting First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD
Conditions: Light Chain Deposition Disease;   Primary Systemic Amyloidosis
Interventions: Drug: pomalidomide;   Drug: bortezomib;   Drug: dexamethasone;   Other: Laboratory Biomarker Analysis
26 Recruiting Escitalopram Effects on CSF Amyloid Beta
Condition: Amyloid Beta Protein
Intervention: Drug: Escitalopram or Placebo
27 Recruiting Study of Captisol Enabled Melphalan and Pharmacokinetics for Patients With Multiple Myeloma or Light Chain Amyloidosis That Are Receiving an Autologous Transplant.
Conditions: Multiple Myeloma;   Amyloidosis
Interventions: Device: Melphalan;   Drug: Pegfilgrastim;   Procedure: Autologous Hematopoietic Progenitor Cell Transplant
28 Recruiting Molecular Imaging of Primary Amyloid Cardiomyopathy
Conditions: Amyloidosis, Primary;   Cardiomyopathy
Interventions: Radiation: F-18 florbetapir/C-11 acetate PET;   Device: MRI
29 Recruiting Phase 1 Study of GSK2315698 in Healthy Japanese Subjects
Condition: Amyloidosis
Interventions: Drug: Placebo;   Drug: GSK2315698
30 Recruiting Modulation of CSF Amyloid-beta Concentrations Via Behavioral Sleep Deprivation and Pharmacological Sleep Induction
Condition: Amyloid-beta
Interventions: Drug: Sodium Oxybate;   Behavioral: Sleep deprivation
31 Recruiting 18F-Florbetaben PET Amyloid Imaging in Case of Intermediate CSF Biology for the Diagnosis of Alzheimer's Disease : a Pilot Study
Condition: Amyloid PET Imaging
Intervention: Device: 18F-Florbetaben PET
32 Recruiting Capacity of Amylose Characterisation Compare by Immunohistochemistry and Proteomic Analysis
Condition: Amyloidosis
Interventions: Other: Immunohistochemistry;   Other: Proteomic analysis
33 Recruiting Amyloïd Load in Elderly Population: Effect of Cognitive Reserve
Conditions: Plaque, Amyloid;   Cognitive Deficits
Interventions: Other: PET;   Other: MRI;   Other: neuropsychological tests
34 Recruiting Prevalence and Post-surgical Outcomes of CARdiac Wild-type TransthyrEtin amyloidoSIs in Elderly Patients With Aortic steNosis Referred for Valvular Replacement.
Conditions: Heart Disease;   Aging;   Amyloidosis;   Aortic Valve Stenosis
Intervention: Other: a basal LV septum biopsy
35 Recruiting Carpal Tunnel Syndrome and Amyloid Cardiomyopathy
Conditions: Amyloidosis;   Cardiomyopathy;   Transthyretin Amyloidosis;   Senile Systemic Amyloidosis;   Carpal Tunnel Syndrome
Intervention:
36 Not yet recruiting Progression of Renal Amyloidosis of FMF and Relation to Serum SAA Level
Condition: Observational
Intervention:
37 Recruiting A Safety and Tolerability Study of an Investigational Drug, ALN-TTRSC02, in Healthy Subjects
Condition: Transthyretin-mediated Amyloidosis (ATTR Amyloidosis)
Interventions: Drug: ALN-TTRSC02;   Drug: Sterile Normal Saline (0.9% NaCl)
38 Available Expanded Access Protocol of Patisiran for Patients With Hereditary ATTR Amyloidosis (hATTR)
Conditions: TTR-mediated Amyloidosis;   Amyloidosis, Hereditary;   Amyloid Neuropathies, Familial;   Familial Amyloid Polyneuropathies;   Amyloid Neuropathies;   Amyloidosis, Hereditary, Transthyretin-Related
Intervention: Drug: patisiran (ALN-TTR02)
39 Not yet recruiting Methods of Etiological Diagnosis of Cerebral Amyloid Angiopathy
Conditions: Cerebral Amyloid Angiopathy;   Intracerebral Hemorrhage
Intervention:
40 Not yet recruiting Florbetaben as an Amyloid Plaque Marker in Elderly Patients With Focal or Disseminated Superficial Hemosiderosis
Conditions: Amyloid Cerebral Angiopathy;   Alzheimer Disease
Interventions: Device: Pet scan with FBB;   Device: MRI scan;   Biological: APO E genotyping

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.